Status:
COMPLETED
Sleep Homeostasis in Parkinson's Disease
Lead Sponsor:
Salvatore Galati
Conditions:
Parkinson Disease
Eligibility:
All Genders
45-75 years
Brief Summary
Parkinson's disease is characterized in the advanced phases by an altered response to dopaminergic therapy for the occurrence of abnormal movements called dyskinesias, that worsens the quality of life...
Detailed Description
Wakefulness in PD is frequently interrupted by sleep episodes, even rapid eye movement sleep (REM), whilst nocturnal sleep is disturbed by abnormal motor activity interference, such as REM sleep behav...
Eligibility Criteria
Inclusion
- clinical characteristics of the patients must be according the UK (United Kingdom) Brain Bank
Exclusion
- anamnestic obstructive sleep apneas syndrome
- known cognitive deterioration or with MMSE (Mini-Mental State Examination) ≤24/30
- depression ≥ 20 of the BDI scale (Beck Depression Inventory)
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02200887
Start Date
September 1 2013
End Date
June 1 2015
Last Update
April 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Regionale di Lugano
Lugano, Canton Ticino, Switzerland, 6903